Children being treated with medication for attention deficit hyperactivity disorder suffer through hallucinations and psychotic symptoms at a higher rate than previously thought, a new study suggests.

The study by the U.S. Food and Drug Administration identified more than 850 instances where children being treated for ADHD with drugs like Ritalin, Adderall XR, Focalin and Metadate CD had hallucinations, many times involving snakes, insects and worms crawling on them

A so-called "memory pill" that was originally designed to treat Alzheimer's disease could be available in a weaker form over-the-counter in the next few years.

Three pharmaceutical companies are working on their own versions of the drug - AstraZeneca and Targacept are collaborating on a version, and Epix Pharmaceuticals is working on its own. The drugs are aimed at older patients suffering from age-related memory loss

Children and teens with attention deficit hyperactivity disorder (ADHD) should get careful cardiac evaluation and monitoring - including an electrocardiogram (ECG) - before starting treatment with stimulant drugs, the American Heart Association now says.

Attention Deficit Hyperactivity Disorder (ADHD) is a condition that becomes apparent in some children in the preschool and early school years. It is hard for these children to control their behavior and/or pay attention

The Food and Drug Administration has expressed its concern over the recent use of attention deficit and hyperactivity disorder, or ADHD drug for tackling the problem of childhood obesity. Since the amphetamine Adderall has the side effects in the form of weight loss in ADHD patients, many doctors are now using the drug for overweight teenagers.

The new controversial approach of prescribing the amphetamine Adderall to teen weight loss has been criticized by FDA as it says patients with previous heart problems have suffered sudden death

The Food and Drug Administration (FDA) has directed the manufacturers of drugs approved for attention deficit hyperactivity disorder (ADHD) to add cautions of possible adverse cardiovascular and psychiatric adverse events to the literature for patients and caretakers.

The FDA advises that the manufacturers must now provide Patient Medication Guides outlining potential risks and precautions for the use of these various ADHD drugs. These guides are provided through the pharmacy when a prescription is filled